PHARMACEUTICAL PRODUCTION IN UZBEKISTAN: DEVELOPMENT STATUS AND REGIONAL DISTRIBUTION (JANUARY–AUGUST 2026)
PDF

Keywords

pharmaceutical industry, medicines, domestic production, production volume, regional distribution, statistical analysis, import substitution.

How to Cite

Razikova Dilnoza. (2026). PHARMACEUTICAL PRODUCTION IN UZBEKISTAN: DEVELOPMENT STATUS AND REGIONAL DISTRIBUTION (JANUARY–AUGUST 2026). Sog‘liqni Saqlashda Yangi Yondashuvlar, 1(7), 43-49. https://doi.org/10.5281/zenodo.23350315

Abstract

This article examines the state of pharmaceutical production in Uzbekistan during January–August 2026, based on publicly available official statistical data. It analyzes production volumes and changes compared with the corresponding period of the previous year, highlighting differences between regions. The findings indicate that production is concentrated in certain regions. The article provides recommendations for expanding the technological capabilities of the domestic pharmaceutical industry, strengthening cooperation between scientific research and production, and conducting a comprehensive analysis of statistical indicators characterizing the market. Since the analysis relies exclusively on publicly available secondary data, the conclusions are limited to the scope of those data.

PDF

References

[1] O‘zbekiston Respublikasi Milliy statistika qo‘mitasi. “Pharmaceutical Production in Uzbekistan Increased by 24.9%”. 2026-yil 9-oktabr. https://stat.uz/en/press-center/news-of-committee/70549-zbekistonda-farmatsevtika-ma-sulotlari-ishlab-chi-arish-azhmi-24-9-foizga-oshdi-4

[2] O‘zbekiston Respublikasi Prezidentining 2026-yil 5-martdagi PF-35-son Farmoni. Farmatsevtika mahsulotlari ishlab chiqarishini rag‘batlantirish va ilmiy tadqiqotlarni takomillashtirishga oid hujjat. https://lex.uz/uz/acts/8076453

[3] World Health Organization, Regional Office for Europe. Availability and prices of essential medicines in Uzbekistan in 2021. 2023. https://www.who.int/switzerland/publications/i/item/9789289058643